While the relationships between obesity, diet, and metabolic endotoxaemia have received particular attention, epidemiological data also implicate circulating endotoxin in risk for type 2 diabetes. Higher plasma LPS concentrations have been reported in both adults with impaired fasting glucose relative to healthy controls and those with overt type 2 diabetes. In addition, a larger analysis involving the FINRISK97 cohort of ~6600 Finnish adults found that circulating endotoxin concentrations at baseline were significantly higher in the individuals with type 2 diabetes and were predictive of those who developed overt type 2 diabetes over the 10- year follow- up period. Likewise, another prospective study, which quantified total 16s rDNA concentration present in the circulation, as a surrogate of intestinal permeability, at baseline and following nine years of follow- up, found that higher baseline concentrations were predictive of type 2 diabetes development over follow- up. Given these relationships, understanding the physiological responses to increased transit of microbial moieties across the gut mucosa may provide further insight into the pathogenesis of type 2 diabetes.

While the impact of sepsis on glucose metabolism has been established, ethical and logistical challenges mean that few studies have directly manipulated plasma LPS and/or the intestinal microbiota as a way to establish causality for type 2 diabetes. However, LPS infusion in a mouse model has been shown to induce changes in insulin sensitivity and glucose levels, supporting a causal role for metabolic endotoxaemia in type 2 diabetes development. Chronic low- dose subcutaneous LPS infusion (300 μg/ kg/d) over four weeks elicited increases in fasting glucose and insulin, impaired glucose clearance in response to an oral glucose load, and increased hepatic gluconeogenesis, all suggesting the loss of glycaemic control. In healthy humans, the acute effects of intravenous LPS infusion (20 U/kg ~2 ng/kg total dose) have been assessed during a 10- hour euglycaemic hyperinsulinaemic clamp protocol and significant reductions in glucose utilization were noted. Subsequent studies have also reported decreases in insulin sensitivity and increased insulin resistance in response to low- dose LPS infusion protocols, further implicating LPS as a causal factor in the development of insulin resistance.

اخر الاخبار

اخبار العتبة العباسية المقدسة

قسم العلاقات العامة ينظّم برنامجًا ثقافيًّا لوفد أكاديمي من جامعة كربلاء

قسم الشؤون الخدمية ينفّذ حملة لتنظيف محيط مرقد أبي الفضل العباس (عليه السلام)

معهد القرآن الكريم النسوي يواصل برنامج الختمات القرآنية الرمضانية

ضمن برنامج يبلغون.. محافظة المثنى تشهد إقامة 8 مجالس قرآنية رمضانية

المزيد

الآخبار الصحية

الماء المملح.. فائدة حقيقية أم "صيحة زائفة"؟

عادة بسيطة تدعم الصحة وتحافظ على الوزن المثالي

الغذاء النباتي يقلل مخاطر السرطان.. مع استثناء مهم

الحليب قليل أم كامل الدسم.. أيهما أفضل؟

المزيد

الآخبار التكنلوجية

أنثروبيك تتحدى البنتاغون.. وترامب يأمر بوقف التعامل معها

ميزة جديدة من "إنستغرام" لحماية المراهقين من الانتحار

الأولى من نوعها.. "تقنية مذهلة" في هاتف سامسونغ الجديد

لماذا تشعر المرأة بالألم أكثر من الرجل؟.. دراسة تجيب

المزيد

مواضيع ذات صلة

Water is an Excellent Nucleophile

Interaction with Water Influences the Structure of Biomolecules

Fibrin Clots Are Dissolved by Plasmin

The Activity of Antithrombin, an Inhibitor of Thrombin, Is Increased by Heparin

Conversion of Fibrinogen to Fibrin Is Catalyzed by Thrombin

Factor Xa Leads to Activation of Prothrombin to Thrombin

Most Transmembrane Proteins Have Membrane Spanning α Helices

Lipid Composition Is Different in the Exoplasmic and Cytosolic Leaflets

Lipid Composition Influences the Physical Properties of Membranes

The Intrinsic Pathway Also Leads to Activation of Factor X

The Extrinsic Pathway Leads to Activation of Factor X

Both Extrinsic & Intrinsic Coagulation Pathways Result in the Formation of Fibrin